Global Antibiotics Market Analysis by Manufacturers, Materials and Technological Enhancement 2020
Global Antibiotics Market Research Report: By Drug class (Cephalosporins, Penicillin, Macrolides, Carbapenem, Aminoglycosides, Sulfonamides, Others), By Spectrum of Activity (Broad-spectrum Antibiotic, Narrow-spectrum Antibiotic), By Drug Origin (Natural, Semi-synthetic, Synthetic) and By End-User (Hospitals & Clinics, Research Organizations, Others) – Forecast to 2025
Market Highlights:
According to MRFR
analysis, Antibiotics
Market is expected to register
a CAGR of 4.8% during the forecast period of 2019 to
2025 and was valued at USD 51,835 Million in 2018.
Antibiotics are powerful
medicines that fight bacterial infections. They either stop bacteria from reproducing
or destroy them. Several types of antibiotics are available, and they are
generally available with a prescription in most countries.
The growth of global
antibiotics market is driven by various factors such as increasing efforts
undertaken by major companies for the development of advanced antibiotic
products, development of generic drugs, increasing approval of antibiotic
drugs, rise in incidence of chronic and infectious diseases, growing investment
opportunities by biotech companies in research and development, is expected to
drive the growth of the global antibiotics market.
Several market players
currently dominate the global antibiotics market. The key players are involved
in product launches and strategic collaborations to strengthen their market
positions.
Market Influencers
An increasing number of antibiotics in the clinical
development stage. In June 2019, approximately 42 new antibiotics with the
ability to treat severe bacterial infections were in the clinical development
stage. As a result, increasing the number of antibiotics would drive the demand
for the global antibiotics market
Avail
a Free Sample@ https://www.marketresearchfuture.com/sample_request/8447
Segmentation
The global antibiotics
market has been segmented based on drug class, spectrum of activity, drug
origin, and end user.
The market, based on drug
class, has been divided into cephalosporins, penicillin, fluoroquinolones,
macrolides, carbapenem, aminoglycosides, sulfonamides, and others. The
carbapenem segment is likely to be the fastest growing during the review period
due to the increasing incidence of pneumonia, urinary tract infections, which
would increase the usage of the carbapenem class of antibiotics. Thus, the
rising usage of carbapenem will substantially drive the growth of the
antibiotics market.
The global antibiotics market has been bifurcated,
based on spectrum of activity, into broad-spectrum antibiotics and
narrow-spectrum antibiotics. The broad-spectrum antibiotic segment is expected
to hold the majority share of the market as this broad-spectrum antibiotic act
against a wide range of diseases, which helps to fight against microbial
resistance.
The global antibiotics market has been segmented
based on drug origin into natural, semisynthetic, and synthetic. Semisynthetic
is expected to be the fastest segment owing to fewer side-effects and has a
higher spectrum of activity, which would eventually drive the growth of the
antibiotic market in this segment.
The global antibiotics market has been segmented
based on drug origin into natural, synthetic, and semisynthetic.
The end user segment of the antibiotics
market includes hospitals & clinics, research organizations, and others.
The hospitals & clinics segment is expected to hold the largest share of
the market as the majority of treatments and procedures are carried out in
hospitals, which ultimately increases the usage of antibiotics in the
antibiotics market. For instance, according to centers for disease control and
prevention (CDC), in 2018, use of the most antibiotics in hospitals increased
by nearly 40% for carbapenems and more than 30% for vancomycin. As a result,
driving the growth of the antibiotics market.
Regional Analysis
The market has been
divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle
East & Africa. The Americas is expected to be the largest market owing to
the increasing adoption of antibiotics. The antibiotics market in the Americas
has further been branched into North America and Latin America, with the North
American market divided into the US and Canada. The European antibiotics market
has been categorized as Western Europe and Eastern Europe. The Western European
market has further been classified as Germany, France, the UK, Italy, Spain,
and the rest of Western Europe. The antibiotics market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. Easy availability of antibiotic drugs and the rise in
over-the-counter antibiotic medicines has boosted the growth of the antibiotics
market, the market in Asia-Pacific is expected to be the fastest-growing. The
antibiotics market in the Middle East & Africa has been divided into the
Middle East and Africa.
Market Restraints
- Increasing antibiotic-resistant infections. In
the US, every year, approximately 2 million people are infected with
antibiotic-resistant bacteria, and at least 23,000 people die as a result
of this.
- Rise in drug approval costs
Access Report Details @ https://www.marketresearchfuture.com/reports/antibiotics-market-8447
The report for Global market by Market
Research Future comprises of extensive primary research along with the detailed
analysis of qualitative as well as quantitative aspects by various industry
experts, key opinion leaders to gain a deeper insight of the market and
industry performance. The report gives a clear picture of the current market
scenario which includes past and estimated future market size with respect to
value and volume, technological advancement, macro economical and governing factors
in the market. The report provides detail information about and strategies used
by top key players in the industry. The report also gives a broad study of the
different market segments and regions.
Global Market – Competitive
Dashboard
Some of the key
players in the Global Antibiotics
Market are Novartis AG (Switzerland), Bristol-Myers Squibb Company (US),
Astellas Pharma Inc. (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Pfizer
Inc. (US), Johnson & Johnson Services, Inc. (US), Abbott Laboratories
(US), GlaxoSmithKline PLC (UK), Sanofi (France), Bayer AG (Germany), Eli
Lilly and Company (US), and Merck & Co., Inc. (US).
TOC:
1.
Report Prologue
2. Market
Introduction
2.1
Definition
2.2 Scope of the Study
2.2.1
Research Objective
2.2.2
Assumptions
2.2.3
Limitations
3. Research
Methodology
3.1 Introduction
3.2 Primary
Research
3.3 Secondary research
3.4 Market Size
Estimation
TOC…Continued
Ask
Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/8447
About Market Research Future:
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by Components, Application, Logistics and market
players for global, regional, and country level market segments, enable our
clients to see more, know more, and do more, which help to answer all their
most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone: +1 646 845 9312
Comments
Post a Comment